...
首页> 外文期刊>Frontiers in Public Health >Novel Dutch Self-Assessment Biosecurity Toolkit to Identify Biorisk Gaps and to Enhance Biorisk Awareness
【24h】

Novel Dutch Self-Assessment Biosecurity Toolkit to Identify Biorisk Gaps and to Enhance Biorisk Awareness

机译:新颖的荷兰自我评估生物安全工具包,可识别生物风险缺口并增强生物风险意识

获取原文

摘要

Life sciences, biotechnology, and medical biology are indispensable research fields for public health and the development of therapeutics and vaccines. However, biological agents and information developed to better health, welfare, and safety, could be misused for harmful purposes to cause damage to public health, safety, and the environment (1–3), which is termed the “dual-use” aspect of research in the life sciences. Laboratory biosafety describes containment principles, technologies, and practices to protect people from biological agents, and prevent accidental release of biological agents (4). In addition to biosafety, laboratory biosecurity measures aim to prevent theft and intentional or malicious use of biological agents (4). Thus, both biosafety and biosecurity should be an integral part of program management of organizations handling dangerous pathogens, in order to prevent potential dual-use research, undesired spread, theft, malicious use, and bioterrorism.
机译:生命科学,生物技术和医学生物学是公共卫生以及治疗剂和疫苗开发必不可少的研究领域。但是,为更好地改善健康,福利和安全而开发的生物制剂和信息可能会出于有害目的而被滥用,从而对公共健康,安全和环境造成损害(1-3),这被称为“双重用途”生命科学领域的研究。实验室生物安全性描述了遏制原则,技术和实践,以保护人们免受生物制剂的侵害,并防止生物制剂的意外释放(4)。除了生物安全性,实验室的生物安全措施还旨在防止盗窃以及故意或恶意使用生物制剂(4)。因此,为了防止潜在的双重用途研究,不希望的传播,盗窃,恶意使用和生物恐怖主义,生物安全性和生物安全性应成为处理危险病原体的组织的计划管理的组成部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号